Innosphere Ventures welcomes new Board Director  Liz Scott, a life science Strategist, Business Developer, and Portfolio/Lifecycle Manager with expertise in commercialization, including sales, marketing and patient access at both large and small companies. Liz is currently Vice President of Sales at Applied Therapeutics, Inc., an emerging biotechnology company developing medicines for rare diseases.  

Liz is actively engaged in the Colorado start-up scene, having founded Fairview Consulting, LLC, a strategy consulting firm helping local life science start-ups commercialize. She also serves as mentor, advisor, and consultant to local start-ups through Venture Partners CU Boulder, CU Innovations, and the Office of Economic Development and Information Technology (OEDIT). 

While Liz has opportunities to work with many organizations, she joins the Innosphere Ventures board because she likes the elevated level of standards and accountability that Innosphere Ventures promotes as an organization and with its clients.  As Liz stated to Innosphere CEO, Mike Freeman,  “Innosphere is a well-oiled machine and its programming is having a tremendous impact on its client companies, and ultimately the customers and markets they serve.  Your leadership team has done a phenomenal job communicating the organization’s strategy, and with its recent momentum, future opportunities appear limitless.”  

Liz’s strategic leadership is poised to further support Innosphere Ventures’ clients to reach their business goals. “I am a strategist at heart– from pipeline management to product development, sales, or marketing– developing a long-term strategy and execution plan is essential for success,” Liz expressed with enthusiasm.  

Liz also brings a vast network in the biotech and pharmaceutical industries, having worked in investor relations and at companies like Genentech, Array Biopharma, BioCryst Pharmaceuticals, Reata Pharmaceuticals, etc. Being local and readily available, she’s eager to get involved and provide support to Innosphere client companies by leveraging her connections to link them with key industry contacts. Liz has expressed a strong commitment to being actively engaged in her new role as board director.